Yang Sheng, Deputy Director of the National Medical Products Administration of China, met with a delegation led by Yang Du, Deputy Director of the U.S. Food and Drug Administration (FDA), yesterday (27th). Both sides fully affirmed the positive results achieved in China-U.S. drug regulatory cooperation and expressed their intention to continue practical cooperation to jointly promote more and better products benefiting the people of both countries.

The Chinese side introduced the latest progress in drug regulation in mainland China and reported on the review and approval of the Implementation Regulations of the Drug Administration Law. The U.S. side reported on key work in areas such as ensuring the drug supply chain, constructing a regulatory framework for digital health products, and building regulations for medical device quality management systems. Both sides also engaged in in-depth exchanges on drug import and export policies, pharmacovigilance, and the application of new methodologies